Skip to main content
Novartis
language-selector-globe Italia | it
Siti Novartis
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Italia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Chi siamo 
      • Novartis in Italia 
      • La nostra missione 
      • Aree di attività 
        • Aree terapeutiche 
      • Diversity & Inclusion 
      • La nostra storia 
        • Le nostre origini 
        • Dal 1996 a oggi 
      • Persone 
      viale affollato Chi siamo
    • Per il paziente 
      • Il nostro impegno 
      • Alleati per la Salute 
        • Politiche Sanitarie e Socio Assistenziali 
        • A fianco di chi aiuta 
        • Benessere psicofisico 
        • News dalle Associazioni Pazienti 
        • Mini Lessons EUPATI 
        • Servizi e materiali utili 
        • Novartis Influencer Masterclass for Patients 
        • HTA - Nuovo regolamento 
        • Attualità 
      • Informazione e sensibilizzazione 
        • Campagne di informazione e sensibilizzazione 
      • Linea Embrace per la gestione delle malattie croniche 
      • Segnalazione effetti indesiderati 
      Un medico tiene le mani a un paziente Per il paziente
    • Sostenibilità 
      • Sostenibilità ambientale 
      • Etica e compliance 
      • Diversity & Inclusion 
      • Accesso e diritto alla salute 
      • Salute globale 
      • Reporting 
      • Indici ESG 
      Young patients waiting outside hospital in Rwanda Sostenibilità
    • Ricerca e innovazione 
      • Ricerca & sviluppo 
      • Nuove frontiere della R&S 
      • Novartis, la ricerca clinica in Italia nel 2023 
      • Open Innovation 
      • Professionisti della salute 
      dettaglio di una confezione di pillole Ricerca e innovazione
    • Lavora con noi 
      • Opportunità di lavoro 
      • Come lavoriamo 
      • Benessere 
      • Benefit 
      • Diversity & Inclusion 
      • Riconoscimenti e certificazioni 
      • La nostra cultura 
      Lavora con noi Lavora con noi
    • News 
      • Fatti e notizie 
      • Area riservata ai giornalisti 
      • Comunicati stampa 
      News News
    • Contatti 
    Homepage Italia Home
  1. Home
  2. Lavora con noi
  3. Cerca offerte di lavoro
  • Sort by Sort ascending
  • Titolo di lavoro
  • Site
  • Posizione
  • Divisione Sort descending
  • Business
  • Area funzionale
  • Data di pubblicazione
Titolo di lavoro Site Posizione Divisione Sort descending Business Area funzionale Data di pubblicazione
Regulatory Affairs Systems & Strategy Manager London (The Westworks) Regno Unito Development Innovative Medicines Technology Transformation Set 02, 2024
Regulatory Affairs CMC Senior Manager Schaftenau Austria Development Innovative Medicines Research & Development Set 02, 2024
Global Regulatory Publishing Specialist London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Set 02, 2024
Manager Regulatory Affairs Process Excellence London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Set 02, 2024
Global Regulatory Submission Manager London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Set 02, 2024
Global Regulatory Affairs Manager Medical Devices (UK or Austria) London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Set 02, 2024
Manager Regulatory Policy & Intelligence London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Set 02, 2024
Regulatory Affairs Medical Device Manager (Schaftenau, Austria) Schaftenau Austria Development Innovative Medicines Research & Development Set 02, 2024
Global Labeling Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Set 02, 2024
Global Regulatory Submission Manager London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Set 03, 2024
Director, Capabilities & Engagement, Clinical Development Dublin (Novartis Corporate Center (NOCC)) Irlanda Development Innovative Medicines Research & Development Set 02, 2024
Senior Expert, Science & Technology (Analytical Expert) Hyderabad (Office) India Development Innovative Medicines Research & Development Set 03, 2024
Clinical Development Functional Head London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Set 03, 2024
RA CMC Associate Manager-II Hyderabad (Office) India Development Innovative Medicines Research & Development Set 03, 2024
Patient Safety Specialist İstanbul Kavacık Turchia Development Innovative Medicines Research & Development Giu 10, 2024
Head CD Pediatric CoE East Hanover USA Development Innovative Medicines Research & Development Giu 13, 2024
Global Program Head, Neuroscience East Hanover USA Development Innovative Medicines Research & Development Lug 16, 2024
RA CMC Associate Manager - II Hyderabad (Office) India Development Innovative Medicines Research & Development Giu 19, 2024
RA CMC Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Set 03, 2024
Manager, Clinical Disclosure Office Barcelona Gran Vía Spagna Development Innovative Medicines Research & Development Giu 20, 2024
Principal Biostatistician Shanghai (Shanghai) Cina Development Innovative Medicines Research & Development Giu 20, 2024
Senior Expert Science & Technology-Photochemistry Changshu (Jiangsu Province) Cina Development Innovative Medicines Research & Development Giu 28, 2024
Patient Safety Head US East Hanover USA Development Innovative Medicines Research & Development Giu 28, 2024
Associate Director, Clinical QA East Hanover USA Development Innovative Medicines Quality Set 24, 2024
Associate Director Strategy and Operations Hyderabad (Office) India Development Innovative Medicines Research & Development Set 24, 2024
Principal Clinical Data Manager Dublin (Novartis Corporate Center (NOCC)) Irlanda Development Innovative Medicines Research & Development Set 26, 2024
Clinical Development Medical Director - Cardio-Renal-Metabolism East Hanover USA Development Innovative Medicines Research & Development Set 26, 2024
Senior Expert Data & Digital Hyderabad (Office) India Development Innovative Medicines Data and Digital Set 27, 2024
Compliance Regulatory Affairs Manager London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Ott 03, 2024
Lead, Capability Learning Solutions Hyderabad (Office) India Development Innovative Medicines Risorse umane Ott 03, 2024
Senior Quality Manager (m/f/d) Schaftenau Austria Development Innovative Medicines Quality Ott 03, 2024
Sr Prin Clinical Data Scientist (Data Mgr) East Hanover USA Development Innovative Medicines Research & Development Ott 03, 2024
Senior Regulatory Affairs Manager London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Ott 04, 2024
Senior Principal Biostatistician London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Ott 04, 2024
Regulatory Affairs Manager New South Wales (NSW) Australia Development Innovative Medicines Research & Development Ott 06, 2024
RA Manager, Procedural Documents London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Set 10, 2024
RA GDD Project Specialist London (The Westworks) Regno Unito Development Innovative Medicines Strutture e amministrazione Set 10, 2024
Director, Global Operational Excellence East Hanover USA Development Innovative Medicines Research & Development Set 11, 2024
Global R&D QMS Senior Specialist Hyderabad (Office) India Development Innovative Medicines Quality Set 11, 2024
Senior Regulatory Affairs Manager Vietnam Vietnam Development Innovative Medicines Research & Development Ott 08, 2024
Head, Clinical Development Strategy & Integration Lead Basel (City) Svizzera Development Innovative Medicines Research & Development Set 12, 2024
Manager, Reg&Dev Policy Japan​ Head Office (Japan) (Pharmaceuticals) Giappone Development Innovative Medicines Research & Development Set 12, 2024
Associate Director- Clinical Data Standards Mumbai (Office) India Development Innovative Medicines Research & Development Set 13, 2024
Strategy and Operations Manager London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Set 13, 2024
Lead Principal CDS Specialist Mumbai (Office) India Development Innovative Medicines Research & Development Set 15, 2024
Senior Global Risk Management Plan Manager Barcelona Gran Vía Spagna Development Innovative Medicines Research & Development Set 16, 2024
Principal Biostatistician Home Worker Regno Unito Development Innovative Medicines Research & Development Set 17, 2024
Director Quantitative Safety Scientist Dublin (Novartis Corporate Center (NOCC)) Irlanda Development Innovative Medicines Research & Development Set 17, 2024
Global Labeling Compliance & Project Lead London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Set 30, 2024
Global Labelling Systems & Project Lead London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Set 30, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis Farma S.p.A Viale Luigi Sturzo, 43 - 20154 Milano (MI) tel. 02/9654.1
C.F. 07195130153 / P.IVA 02385200122

Novartis Italia

Naviga
  • Per il paziente
  • Professionisti della salute
  • Sostenibilità
  • News
  • Lavora con noi
  • Novartis nel mondo
News
  • Archivio news
  • Fatti & Notizie
  • Comunicati Stampa
  • Area riservata ai giornalisti
Siti web Novartis
  • Sito del gruppo
Footer Bottom
© 2024 Novartis Italia
  • Avvertenze legali
  • Privacy Policy
  • Contatti
  • Impostazioni cookie
  • Mappa del sito
  • Accessibilità
Elenco siti Novartis
Questo sito è destinato a utenti residenti in Italia